SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-018231
Filing Date
2023-05-19
Accepted
2023-05-19 08:20:23
Documents
12
Period of Report
2023-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 30708
  Complete submission text file 0001493152-23-018231.txt   201897

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE qlgn-20230516.xsd EX-101.SCH 3236
3 XBRL LABEL FILE qlgn-20230516_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE qlgn-20230516_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3493
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 23937953
SIC: 2834 Pharmaceutical Preparations